Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × fludarabine phosphate × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 95 Leukemia, Myeloid, Acute 85 Leukemia 82 Myelodysplastic Syndromes 76 Lymphoma, Non-Hodgkin 62 Lymphoma 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Hodgkin Disease 57 Multiple Myeloma 55 Lymphoma, Mantle-Cell 46 Lymphoma, Follicular 43 Lymphoma, Large B-Cell, Diffuse 42 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38 Lymphoma, B-Cell, Marginal Zone 37 Myeloproliferative Disorders 36 Leukemia, Myelomonocytic, Chronic 32 Congenital Abnormalities 32 Burkitt Lymphoma 32 Melanoma 30 Primary Myelofibrosis 27 Lymphoma, Large-Cell, Immunoblastic 27 Leukemia, Myeloid, Chronic-Phase 27 Leukemia, Myeloid, Accelerated Phase 26 Waldenstrom Macroglobulinemia 24 Blast Crisis 23 Hematologic Neoplasms 22 Recurrence 20 Neoplasms, Plasma Cell 20 Lymphoma, T-Cell, Cutaneous 20 Leukemia, Prolymphocytic 20

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡